Supported Exercise Programme for Adults With Congenital Heart Disease
SEACHange
1 other identifier
interventional
28
1 country
1
Brief Summary
This study will evaluate if the introduction of a supported exercise programme can improve physical and psychological well-being for adults with congenital heart disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2017
CompletedStudy Start
First participant enrolled
June 2, 2017
CompletedFirst Posted
Study publicly available on registry
August 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2018
CompletedJuly 31, 2019
July 1, 2019
1.6 years
April 7, 2017
July 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Attendance rate
Determine the feasibility of introducing a supported exercise programme in to clinical practice. This will be measured through attendance to the programme and interaction with the online resource.
12 weeks (for each phase)
Attrition rate
Determine the feasibility of introducing a supported exercise programme by assessing attrition rate throughout the study period.
12 weeks (for each phase)
Secondary Outcomes (9)
Change in six minute walk test (6MWT)
12 weeks (for each phase)
Change in Sniff Nasal Inspiratory Pressure (SNIP)
12 weeks (for each phase)
Change in Grip Strength
12 weeks (for each phase)
Is there an improvement in level of psychological distress
12 weeks (for each phase)
Is there an improvement in level of psychological distress
12 weeks (for each phase)
- +4 more secondary outcomes
Study Arms (4)
Study Group One
OTHERSix Minute Walk Test distance \<450metres. Exercise programme including inspiratory muscle trainer for 12 weeks. Contact weekly (via phone or email).
Study Group Two
OTHERSix Minute Walk Test distance \>450metres. Exercise programme including walking for 12 weeks. Contact every second week (via phone or email).
Study Group One - phase 2
OTHERSix Minute Walk Test distance \<450metres. Exercise programme including inspiratory muscle trainer for 12 weeks. Contact weekly (via phone or email).
Study Group Two - phase 2
OTHERSix Minute Walk Test distance \>450metres. Exercise programme including walking for 12 weeks. Contact every second week (via phone or email).
Interventions
Complete background demographics, Sniff Nasal Inspiratory Pressure (study group one only), grip strength, muscle strength, PHQ-9 and GAD-7 questionnaires.
Eligibility Criteria
You may qualify if:
- Living in Scotland
- Diagnosis of congenital heart disease
- Walks less than 450 metres on a 6 minute walk test (Group 1)
- Walks more than 450 metres on a 6 minute walk test (Group 2)
You may not qualify if:
- No access to internet or telephone
- Non English speaking (If the pilot study is successful, we anticipate that materials and programmes could be translated and accessible to non English speakers)
- Vulnerable adults
- Severe aortic stenosis or severe left ventricular outflow tract obstruction (LVOTO)
- Eisenmenger Physiology (ongoing study recruitment with SPVU)
- Currently prescribed Advanced Pulmonary Vasodilator therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Golden Jubilee National Hospital
Clydebank, G81 4DY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Maureen Mason, MSc
Golden Jubilee Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2017
First Posted
August 25, 2017
Study Start
June 2, 2017
Primary Completion
December 21, 2018
Study Completion
December 21, 2018
Last Updated
July 31, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share
No plan to share individual data